{"ticker": {"uuid": "793178a6-33e6-4653-96a5-81c80d91b147", "symbol": "A", "name": "Agilent Technologies Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Life Science Tools Market Top Players- Agilent Technologies,", "summary": "The global Life Science Tools Market, valued at USD 183.09 billion in 2025, is projected to reach USD 461.03 billion by 2035, growing at a 9.8% CAGR. This growth is driven by advancements in research technologies, increased investments, and the rising prevalence of chronic diseas", "url": "https://www.openpr.com/news/4576640/life-science-tools-market-top-players-agilent-technologies", "source_name": "openPR.com", "published_at": "2026-07-14T22:07:07", "published_display": "14 Jul 2026 22:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent receives FDA approval for cancer diagnostic test By Investing.com", "summary": "Agilent Technologies Inc. received FDA approval for its PD-L1 IHC 28-8 pharmDx assay, a companion diagnostic for specific esophageal and gastric cancers. This test identifies patients eligible for treatment with Bristol Myers Squibb's OPDIVO or OPDIVO QVANTIG. The approval expand", "url": "https://za.investing.com/news/stock-market-news/agilent-receives-fda-approval-for-cancer-diagnostic-test-93CH-4368111", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T17:07:02", "published_display": "14 Jul 2026 17:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/agilent-wins-fda-approval-pd-125203838.html", "source_name": "MT Newswires", "published_at": "2026-07-14T12:52:03+00:00", "published_display": "14 Jul 2026 12:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent receives FDA approval for cancer diagnostic test", "summary": "Agilent Technologies Inc. received FDA approval for its PD-L1 IHC 28-8 pharmDx assay, a companion diagnostic for certain esophageal and gastric cancers. This test helps identify patients who may benefit from Bristol Myers Squibb\u2019s OPDIVO treatments. The approval strengthens Agile", "url": "https://www.investing.com/news/company-news/agilent-receives-fda-approval-for-cancer-diagnostic-test-93CH-4790687", "source_name": "Investing.com", "published_at": "2026-07-14T13:06:59", "published_display": "14 Jul 2026 13:06", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma", "summary": "Agilent Technologies Inc. announced FDA approval for its PD-L1 IHC 28-8 pharmDx assay. This companion diagnostic identifies patients with esophageal squamous cell carcinoma, gastric, gastroesophageal junction, and esophageal adenocarcinoma who may be eligible for treatment with B", "url": "https://sg.finance.yahoo.com/news/agilent-receives-fda-approval-pd-120000155.html", "source_name": "Market source", "published_at": "2026-07-14T12:07:08", "published_display": "14 Jul 2026 12:07", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA-approved Agilent test identifies patients who may be eligible for Opdivo", "summary": "Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 pharmDx assay. This diagnostic test identifies patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment ", "url": "https://www.stocktitan.net/news/A/agilent-receives-fda-approval-for-pd-l1-ihc-28-8-pharm-dx-in-sb8zza7owxk8.html", "source_name": "Stock Titan", "published_at": "2026-07-14T12:03:03", "published_display": "14 Jul 2026 12:03", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A6433334 Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the A6433334 bond issued by Agilent Technologies, Inc. The bond has a 4.9% coupon rate and matures on January 15, 2032, with an outstanding amount of $600 million. It also gives a brief overview of Agilent Technologies, Inc., detailing its se", "url": "https://www.tradingview.com/symbols/FINRA-A6433334/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-14T11:36:59", "published_display": "14 Jul 2026 11:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A6433334 Bond Risk Profile", "summary": "This page provides a risk profile for the A6433334 bond from Agilent Technologies, Inc., with a 4.9% coupon rate and maturing on January 15, 2032. It focuses on credit risk assessment by offering key metrics such as security level, inflation protection, and an issuer rating to he", "url": "https://www.tradingview.com/symbols/FINRA-A6433334/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T11:07:07", "published_display": "14 Jul 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock reflects steady diagnostics demand", "summary": "Agilent Technologies provides laboratory instruments and diagnostic solutions to various sectors including pharmaceutical, biotechnology, environmental, and clinical laboratories. The company's stock is supported by recurring demand for long-term trends in testing, research, and ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-stock-reflects-steady-diagnostics-demand/69762405", "source_name": "Ad Hoc News", "published_at": "2026-07-13T22:43:59", "published_display": "13 Jul 2026 22:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/agilent-buy-sell-hold-post-204639451.html", "source_name": "StockStory", "published_at": "2026-07-13T20:46:39+00:00", "published_display": "13 Jul 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Agilent Technologies (A) A Bargain Following Its New Lab Tools And AI Software?", "summary": "Agilent Technologies (A) has introduced new lab tools and AI-powered software, drawing attention to its stock amidst a gradual improvement in sentiment. While valuation narratives suggest the stock is undervalued, its P/E ratio is higher than its fair ratio despite being lower th", "url": "https://www.sahmcapital.com/news/content/is-agilent-technologies-a-a-bargain-following-its-new-lab-tools-and-ai-software-2026-07-13", "source_name": "Sahm", "published_at": "2026-07-13T20:07:01", "published_display": "13 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating", "summary": "Baird has raised its price target for Agilent Technologies (NYSE: A) to $160 from $158, while reiterating an Outperform rating on the stock. This adjustment reflects Baird's positive outlook on the company's future performance.", "url": "https://www.moomoo.com/news/post/72867502/baird-adjusts-agilent-technologies-price-target-to-160-from-158", "source_name": "Moomoo", "published_at": "2026-07-13T18:07:07", "published_display": "13 Jul 2026 18:07", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tangible book value per share of Agilent Technologies, Inc. \u2013 LSX:929138", "summary": "This article provides financial information for Agilent Technologies, Inc. (LSX:929138) focusing on its tangible book value per share. The content appears to be a stub or a placeholder from a financial data platform, indicating where this specific financial metric would be displa", "url": "https://www.tradingview.com/symbols/LSX-929138/financials-statistics-and-ratios/book-tangible-per-share/", "source_name": "TradingView", "published_at": "2026-07-12T08:06:56", "published_display": "12 Jul 2026 08:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent rises on Q2 beats; adjusts fiscal 2026 guidance", "summary": "Agilent Technologies reported strong Q2 earnings that surpassed expectations, leading to a rise in its stock. The company also announced adjustments to its fiscal year 2026 guidance. This positive financial performance indicates a robust quarter for Agilent.", "url": "https://www.msn.com/en-us/news/world/agilent-rises-on-q2-beats-adjusts-fiscal-2026-guidance/ar-AA24dIy6?uxmode=ruby&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-11T22:07:00", "published_display": "11 Jul 2026 22:07", "sentiment": "positive", "sentiment_pct": 85, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock stays supported by life-science demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZVFHUUlyNmVjcFdHT0VEZFBjMWdVSzRQR1pIRkM3Q2JJSUNjSHh0ZlBFTG9ZaFAwQzRTR2dEU3lDSkd0VWhnM20yTG94NjVEQ2FuQ1lReTRKOW56VHhNbGtmbjVFc012X3VidHRya0dYOG52ZnhFUXdYbkhUek1na1Z3blBEWjJlaTVWNC1TRFFQcnRYUW9EUE1peWFGeWl6VEp4SC1xbUp1MUt0TEJXOEJid0lfZW1JYjhleDhtcGFEQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-10T08:04:04+00:00", "published_display": "10 Jul 2026 08:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Agilent (A) Signal a Deeper Shift With New AI Biopharma Tools and Columns?", "summary": "Agilent Technologies has expanded its Altura HPLC column portfolio and introduced the AI-powered xCELLigence RTCA eSight AI module, aiming to enhance data quality, efficiency, and reproducibility in biopharmaceutical research. This move aligns with Agilent's strategy to focus on ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-signal-a-deeper-shift-with-new-ai-biopharma-t", "source_name": "Simply Wall Street", "published_at": "2026-07-10T06:43:59", "published_display": "10 Jul 2026 06:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Strengthens Biopharma Growth Prospects With AI Expansion", "summary": "Agilent Technologies is enhancing its biopharma growth prospects by expanding its AI-enabled laboratory software and automation capabilities, despite recent stock dips. The company launched xCELLigence RTCA eSight AI to simplify live-cell imaging analysis and is integrating AI ac", "url": "https://www.tradingview.com/news/zacks:f7a7597dd094b:0-agilent-strengthens-biopharma-growth-prospects-with-ai-expansion/", "source_name": "TradingView", "published_at": "2026-07-09T18:07:10", "published_display": "09 Jul 2026 18:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies Inc. stock outperforms competitors on strong trading day", "summary": "Shares of Agilent Technologies Inc. (A) rose 3.50% on a strong trading day, outperforming the S&P 500 Index (SPX) and the Dow Jones Industrial Average (DJIA). The stock closed at $133.59, 16.65% below its 52-week high. This performance occurred as the broader market also saw gain", "url": "https://www.marketwatch.com/data-news/agilent-technologies-inc-stock-outperforms-competitors-on-strong-trading-day-a0e33dbe-50606b327369", "source_name": "MarketWatch", "published_at": "2026-07-09T16:53:00", "published_display": "09 Jul 2026 16:53", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat (NASDAQ:ILMN)", "summary": "Illumina (ILMN) holds over 90% market share in genomics sequencing with a robust razor-and-blades model, powering a $30B+ market. Following the GRAIL divestment, management is focusing on core sequencing, cost control, and capital return, leading to revenue recovery and margin ex", "url": "https://seekingalpha.com/article/4920921-while-you-chased-ai-this-healthcare-stock-built-a-30b-moat", "source_name": "Seeking Alpha", "published_at": "2026-07-09T15:10:27", "published_display": "09 Jul 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies explores long-term growth drivers as a life sciences leader", "summary": "Agilent Technologies Inc. is a leading provider of analytical instruments and diagnostic solutions for various industries, including pharmaceuticals and chemicals. The company focuses on high-performance systems like chromatography and mass spectrometry, benefiting from recurring", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-explores-long-term-growth-drivers-as-a-life-sciences/69730476", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T09:43:59", "published_display": "09 Jul 2026 09:43", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies resumes Agilent stock coverage with Hold rating By Investing.com", "summary": "Jefferies has resumed coverage on Agilent Technologies Inc. (NYSE:A) with a Hold rating and a $135 price target, following the company's acquisition of Biocare. The firm expects modest revenue growth and adjusted operating margin accretion from the deal, with slight dilution to e", "url": "https://za.investing.com/news/stock-market-news/jefferies-resumes-agilent-stock-coverage-with-hold-rating-93CH-4361430", "source_name": "Investing.com South Africa", "published_at": "2026-07-08T22:36:58", "published_display": "08 Jul 2026 22:36", "sentiment": "positive", "sentiment_pct": 60, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies resumes Agilent stock coverage with Hold rating", "summary": "Jefferies has resumed coverage on Agilent Technologies Inc. (NYSE:A) with a Hold rating and a price target of $135, following the company's acquisition of Biocare. The firm anticipates modest revenue growth and improved operating margins from the acquisition, though slight diluti", "url": "https://www.investing.com/news/analyst-ratings/jefferies-resumes-agilent-stock-coverage-with-hold-rating-93CH-4782704", "source_name": "Investing.com", "published_at": "2026-07-08T21:51:59", "published_display": "08 Jul 2026 21:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors", "summary": "Agilent Technologies Inc. (A) stock fell 1.58% to $129.07 on Wednesday, underperforming the broader market, as the S&P 500 Index (SPX) dropped 0.28% and the Dow Jones Industrial Average (DJIA) fell 1.09%. The company's stock closed 19.47% below its 52-week high of $160.27.", "url": "https://www.marketwatch.com/data-news/agilent-technologies-inc-stock-underperforms-wednesday-when-compared-to-competitors-d7e40d28-591b52143847?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-08T16:52:00", "published_display": "08 Jul 2026 16:52", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?", "summary": "Evercore ISI analyst Vijay Kumar recently raised the price target for Agilent Technologies, Inc. (A) to $148, maintaining an Outperform rating, following a review of the MedTech, Life Sciences Tools, and Diagnostics sectors. The positive outlook is supported by stable procedure v", "url": "https://www.insidermonkey.com/blog/is-agilent-technologies-inc-a-stock-positioned-for-growth-as-life-sciences-sector-trends-stabilize-1797685/", "source_name": "Insider Monkey", "published_at": "2026-07-08T15:06:58", "published_display": "08 Jul 2026 15:06", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Slumps on Expansion Plans", "summary": "Agilent Technologies Inc. (NYSE: A) shares declined after the company announced an expansion of its Altura HPLC column portfolio, introducing Altura size exclusion chromatography (SEC) and Altura PLRP-S columns. These new columns are designed to support critical analytical workfl", "url": "https://www.baystreet.ca/stockstowatch/23617/Agilent-Slumps-on-Expansion-Plans", "source_name": "Baystreet.ca", "published_at": "2026-07-08T14:06:58", "published_display": "08 Jul 2026 14:06", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/agilent-expands-altura-portfolio-inert-120000327.html", "source_name": "Business Wire", "published_at": "2026-07-08T12:00:00+00:00", "published_display": "08 Jul 2026 12:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Bravo NGS Auto Prep System from Agilent Technologies Inc. - Automating genomic workflows for", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQU2tETjdOa3FxTjdDQVhWTGRMak5aLXNBeUdNdXVWaTl6VXpoOF9XZjZxajhyYWNzaDl0dGUwSmlYOGhKTHFhTkJHQ2hkNVJ0VXdOemZSRkFjSWctNE5TTC1Tc3VYZEwydVhXUDdldTJud3BhR3BCX0UybzlnVkF0VVF1d0k5end0LTY5N0djajRmN3NMOUhBS05scl9qbk1OeTVDSUE5V3dBR2NVRkhnUk12Mk9uWVk0N2Qwb2ZRQk0?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-30T15:56:07+00:00", "published_display": "30 Jun 2026 15:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOQ3dIcEY1SVlJRzRVdm1YbDVMRTdody00UzB0OUhFQVhvenJBNERmNDlBbmZMMEZETzJaeVZfekJvYm9lYkVTdl8tbllZbUcxN1poZmFqX0I2ZXFzUE8zdV9TWlFUSXJUbkhDMFoxOW43amQyX1NzanNIZHI3YVFaZ1VkX1NqLTE0X3REem5paUVEc2dUMzJWSUtLVFhybm8?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Agilent\u2019s Upgraded Outlook and Cancer Diagnostics Push Could Impact Agilent Technologies (A) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-23T17:37:08+00:00", "published_display": "23 Jun 2026 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies (A) Stock Could Be 21.1% Undervalued After Earnings Beat And Higher Outlook", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies Inc. stock (US00846U1016): shares advance after stronger Q2 2026 results and hi", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVkFwNXRTZWNUbnRtV09YRGRSWW5DYjF2OVE1Mk5YZkdwVEpaRmdZSXM2aFlTNWpid0g5aVNYbTg1UHpxaEhudGhoV3ZrVkhQYjF6UEk0UnNpaXJDOXJ4em5ySjFkdkx5VnBXdGRYa250X0pJanRCcEtTN2t3NHJPbzh4bnFDb1lad0N3NDZEU2JJVlJSdV8ybkxGMkFkNllWMFBKNGx1d3E1d1BSZl9LaGRudmFsZHNrcV9XWF9iX04?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "StockWatch: Agilent Shares Jump on Better than Expected Quarterly Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPaXdkbXdJUktZd1FBOEZsY21zUlRBYXNpNmxDWXVhdERad0hqUDdOZlIwOVh1VnRlVWRuOURwUEVqUWV6NHVwWk5IRjBuRTJnejJQNVJFVVNCOF9zNXRfOW0teWJrTHNXSEpzSW93U1B6cnlVTWkzMGhFRzBiTm5qYTlybmpEbUhybTlUQ0drcDhKTjhqLUVuekFzWDZoVktUTUFUekhhWDRnTXJHX2d3a01oXzVYemoyWVc0QklB?oc=5", "source_name": "Genetic Engineering and Biotechnology News", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Agilent Technologies (A) After Its Recent Share Price Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPTXFCVklNeGdBdExpVG9DMkZiY2NaTWd3Qy1JZlhTVFRzOVpIOGJwS0loYWI2cG1mc01sX2NhWWY5ODc4el9nbmNZQm1xbGg5WEVUV3hPMm94WW1IcXhyZVB5ZW1xalljQ0VudE9EWTRvVXBoRUpyMThnZURLV3lUbnZvT1JCSTJuVkdBSHFyRUo3TVZtZG9SZTh3ajV5WUluVzA3S3VBQlpFOWFBa2dWZlUxS3BnUEpSQlBBTFBCYjFfQklGZXFneGQ0d1BWSmRrUmZxTmRObHZwV3VrQjFpMlV30gHnAUFVX3lxTE9FTWJPZlFQSjF1N1ZLeGd4QVhZNEp1VjhjSnhXUnJBeldtUDQ3ZkNNckdHYU9ocldlaE1pSzZDam13TUVaZmVsVXdubEpuSllzTnZlMzcwTmZVN2ZqMzlPY2s0cFNqWjkwRV9QSmFnT0tGYk81R0Exd0l0bjZDczNIN1F4a3BVb1RqM05CYTc3RzJ0U3VJY0RZbW1mZ1JINzFhMDZWbE1VYzdHTnlsd3ZSXzdheEhfalA5OHFkcGtPSUVTMG44c3RCM3l6V3dhTkJlOXpSOVpwUm94c3lwbmlsbWJPeFl1UQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Agilent tool turns paper lab procedures into guided digital workflows", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQNlFZZ2Z0cFZLMTFudEtpZDZTN05pVS1LNDlFcVBDM0ZjTE4xSVpRdWVoWXM2OFVsVWFIcExNNGxuQWZIenh2dENLNzVpV2VYb1lMeUxFVWhIVVluLUxFekNsNFp0Rjc4OURnbU4yOFNQN190NlR6c25LUlpvb2plQmRWWHU4a1Rkb1BYT0VuamJnYkw3ZzBEWjE3QVd6RThMOThXekQzRUpRRDFpT0EwMTVBa2ZVR2d0OEF0UA?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A) Set to Report Earnings with Consensus at $1.41", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdDRyelY3WFFsaXZPbkJvRGw0TGlIWkY1M1lDeG8yV2gyU3ZOSjJtMlFoajZ4eFZqaWNBTFkxbnR0eG0zQzNvZ3NkU1Q0RkRtN3oxUWFtcnlKODU3MXlQZFNzVDVNZ3ZCUndxZ3lOTGRWV1JSM0x1QXNGcWdDMWlESExzY2dCeVZmNFp5UXR5c1hIXzRIV3FndlRqRktvVkc4SUFNa2hQMFQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Healthcare Providers & Services Stocks\u2019 Q1 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOWE1mb0V1RkxaUjhTeXBkZktWRVotYjBPbmg0QXMtbmJRVlpncWQxazh5LUVnTWNXYVNyT3RReWZyd0cyRmVFSHJiUnpscV91MDlpcWIzWFU5OE9DS09Od18xWGtfd3V6R0FYRWlRV1Z6Q2Vnc2tVRS03VkV4OGFxRzFrTlVGTFBtUnNMN3FuTjZHM0xBdHE0aWRpOVN1Z3hYR3RxM2JySnJrQ0Q1?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock (US00846U1016): Dividend hike follows mixed quarterly update", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPcjZjV0N5UmlMQm5BZUdmc1F2ZzJIWXpGRmZmTlphTVlJakRxWkhrWU1wRGx1S19sNlBySkZyS19pbXlWaHJnb2xDUko0bFNhRkZEdDhoZVctdlpPVlp4SVNvdFdrTVdiSENUdnpIdnpTTEVMd2hOa05rN0VzX2xxMTFCNG1VcnM2Zng1OUxDeEI3TFMtdjlDQ202eU9PdUxBTnRmRWlOY1FURVEwVGlRd2VGVmU2Ullmd21XekpMMzBLWG9s?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock (US00846U1016): Earnings update puts demand trends back in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQUhJczl2TVR6dlBYcWg3MzNjcExySm40ajB0NDZpaVVYT08zZU1RLURYQzlTc3c1Z2RCeHE0Y3RVWUhvZHpJcWpaNmMzNTQ1bnc3NWRZRzd1cFdxMU1UVEVrb09ZTjJFQnJVU1JYQjU1WEYwLWxFci1LM1YzeHdqWGNiVXJGS1FYaWhudmhqWm9MY21oMzlpRHlpWEVMQlhpRnl3MjZMemZFNVF6Wng0c2RYd3VqV1dEbWs2MFFabDhoSEZV?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock: Earnings update in focus after latest results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQbkZqSFZPSHdtQTFXV3Znakdsd0s4NE5BOW5wRDUzQ0toZmVJOHNGbkNpaDVMX0F5T2FMem41SDAwcFBNSFdCM1VoX244UE1nLVYxb001VGphY1h1OEJydF9hWnJMR2MzVWpHQWczWGFxVjRhVll2SWdGeTdNQjc4b2Fha2tRQXFwZzBfQ0JhTk44UVRTaUNnMnBwRDRXaVowaFR0WkJMbVB3UmtXbXRScjZ1NlpqUFBCc19XdE1uSVZvNG5jd29qVFFxUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent launches unified CDMO business combining US, Canada units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNZ20teFhQeXIwa2tHN29ha3lRS2hlMVkzTkE0QTlkRlczRlZRRUVBS3YtMGpRcmlXekFtYndianVJQVZBeE1yVk9rVFdnc0FPTXF4LVdyaXN6WXlmYnhSam1lNUlVN0piY3JHRjRNOHNWQ0NNWHVVWU03QmRUdWlSWkJlUEVtdlgtUUUxQ0J0N2NJZzdOaFNkcFJObWVMV3BHWnJ2alFIZHNRS1l1bUl2NWVOZDhfT0VTQ1EwTEp3?oc=5", "source_name": "Investing.com", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Agilent Stock Is Slipping Premarket Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPOUFTbjl6czVuX2hCOEk5RmRFMFVKOUFIa3d3Qlo5LXpwaFMtRG1jcXJuRDFlMlBJbW8yREFzQjJpZnBhUk9HSG5URE9kYlJrLWFGT3ZxTlBYV05hdllqVkFZQzBmdktqeWxDOXNONF9Xb01KbXB0NXVXcDljV2hSTnp4M3RsSUJ1VndsZmRoY3RtSFQ3aEQ0RGtZUTN2RlFnUkRuVHZ5aFhZUkppZlAyMEw0aG9PNFlQZ3FtakNOQTNObWNVd1JzYkxHN0pWTDNySnJ2NW9YQUJRMVhzZTJPSlBrbUk2dk5jN3pR?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies, Inc. (NYSE:A) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-27T08:00:00+00:00", "published_display": "27 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Life Science Tools Market Top Players- Agilent Technologies,", "summary": "The global Life Science Tools Market, valued at USD 183.09 billion in 2025, is projected to reach USD 461.03 billion by 2035, growing at a 9.8% CAGR. This growth is driven by advancements in research technologies, increased investments, and the rising prevalence of chronic diseas", "url": "https://www.openpr.com/news/4576640/life-science-tools-market-top-players-agilent-technologies", "source_name": "openPR.com", "published_at": "2026-07-14T22:07:07", "published_display": "14 Jul 2026 22:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent receives FDA approval for cancer diagnostic test By Investing.com", "summary": "Agilent Technologies Inc. received FDA approval for its PD-L1 IHC 28-8 pharmDx assay, a companion diagnostic for specific esophageal and gastric cancers. This test identifies patients eligible for treatment with Bristol Myers Squibb's OPDIVO or OPDIVO QVANTIG. The approval expand", "url": "https://za.investing.com/news/stock-market-news/agilent-receives-fda-approval-for-cancer-diagnostic-test-93CH-4368111", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T17:07:02", "published_display": "14 Jul 2026 17:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/agilent-wins-fda-approval-pd-125203838.html", "source_name": "MT Newswires", "published_at": "2026-07-14T12:52:03+00:00", "published_display": "14 Jul 2026 12:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent receives FDA approval for cancer diagnostic test", "summary": "Agilent Technologies Inc. received FDA approval for its PD-L1 IHC 28-8 pharmDx assay, a companion diagnostic for certain esophageal and gastric cancers. This test helps identify patients who may benefit from Bristol Myers Squibb\u2019s OPDIVO treatments. The approval strengthens Agile", "url": "https://www.investing.com/news/company-news/agilent-receives-fda-approval-for-cancer-diagnostic-test-93CH-4790687", "source_name": "Investing.com", "published_at": "2026-07-14T13:06:59", "published_display": "14 Jul 2026 13:06", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma", "summary": "Agilent Technologies Inc. announced FDA approval for its PD-L1 IHC 28-8 pharmDx assay. This companion diagnostic identifies patients with esophageal squamous cell carcinoma, gastric, gastroesophageal junction, and esophageal adenocarcinoma who may be eligible for treatment with B", "url": "https://sg.finance.yahoo.com/news/agilent-receives-fda-approval-pd-120000155.html", "source_name": "Market source", "published_at": "2026-07-14T12:07:08", "published_display": "14 Jul 2026 12:07", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA-approved Agilent test identifies patients who may be eligible for Opdivo", "summary": "Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 pharmDx assay. This diagnostic test identifies patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment ", "url": "https://www.stocktitan.net/news/A/agilent-receives-fda-approval-for-pd-l1-ihc-28-8-pharm-dx-in-sb8zza7owxk8.html", "source_name": "Stock Titan", "published_at": "2026-07-14T12:03:03", "published_display": "14 Jul 2026 12:03", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A6433334 Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the A6433334 bond issued by Agilent Technologies, Inc. The bond has a 4.9% coupon rate and matures on January 15, 2032, with an outstanding amount of $600 million. It also gives a brief overview of Agilent Technologies, Inc., detailing its se", "url": "https://www.tradingview.com/symbols/FINRA-A6433334/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-14T11:36:59", "published_display": "14 Jul 2026 11:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A6433334 Bond Risk Profile", "summary": "This page provides a risk profile for the A6433334 bond from Agilent Technologies, Inc., with a 4.9% coupon rate and maturing on January 15, 2032. It focuses on credit risk assessment by offering key metrics such as security level, inflation protection, and an issuer rating to he", "url": "https://www.tradingview.com/symbols/FINRA-A6433334/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T11:07:07", "published_display": "14 Jul 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock reflects steady diagnostics demand", "summary": "Agilent Technologies provides laboratory instruments and diagnostic solutions to various sectors including pharmaceutical, biotechnology, environmental, and clinical laboratories. The company's stock is supported by recurring demand for long-term trends in testing, research, and ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-stock-reflects-steady-diagnostics-demand/69762405", "source_name": "Ad Hoc News", "published_at": "2026-07-13T22:43:59", "published_display": "13 Jul 2026 22:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/agilent-buy-sell-hold-post-204639451.html", "source_name": "StockStory", "published_at": "2026-07-13T20:46:39+00:00", "published_display": "13 Jul 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Agilent Technologies (A) A Bargain Following Its New Lab Tools And AI Software?", "summary": "Agilent Technologies (A) has introduced new lab tools and AI-powered software, drawing attention to its stock amidst a gradual improvement in sentiment. While valuation narratives suggest the stock is undervalued, its P/E ratio is higher than its fair ratio despite being lower th", "url": "https://www.sahmcapital.com/news/content/is-agilent-technologies-a-a-bargain-following-its-new-lab-tools-and-ai-software-2026-07-13", "source_name": "Sahm", "published_at": "2026-07-13T20:07:01", "published_display": "13 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating", "summary": "Baird has raised its price target for Agilent Technologies (NYSE: A) to $160 from $158, while reiterating an Outperform rating on the stock. This adjustment reflects Baird's positive outlook on the company's future performance.", "url": "https://www.moomoo.com/news/post/72867502/baird-adjusts-agilent-technologies-price-target-to-160-from-158", "source_name": "Moomoo", "published_at": "2026-07-13T18:07:07", "published_display": "13 Jul 2026 18:07", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tangible book value per share of Agilent Technologies, Inc. \u2013 LSX:929138", "summary": "This article provides financial information for Agilent Technologies, Inc. (LSX:929138) focusing on its tangible book value per share. The content appears to be a stub or a placeholder from a financial data platform, indicating where this specific financial metric would be displa", "url": "https://www.tradingview.com/symbols/LSX-929138/financials-statistics-and-ratios/book-tangible-per-share/", "source_name": "TradingView", "published_at": "2026-07-12T08:06:56", "published_display": "12 Jul 2026 08:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent rises on Q2 beats; adjusts fiscal 2026 guidance", "summary": "Agilent Technologies reported strong Q2 earnings that surpassed expectations, leading to a rise in its stock. The company also announced adjustments to its fiscal year 2026 guidance. This positive financial performance indicates a robust quarter for Agilent.", "url": "https://www.msn.com/en-us/news/world/agilent-rises-on-q2-beats-adjusts-fiscal-2026-guidance/ar-AA24dIy6?uxmode=ruby&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-11T22:07:00", "published_display": "11 Jul 2026 22:07", "sentiment": "positive", "sentiment_pct": 85, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock stays supported by life-science demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZVFHUUlyNmVjcFdHT0VEZFBjMWdVSzRQR1pIRkM3Q2JJSUNjSHh0ZlBFTG9ZaFAwQzRTR2dEU3lDSkd0VWhnM20yTG94NjVEQ2FuQ1lReTRKOW56VHhNbGtmbjVFc012X3VidHRya0dYOG52ZnhFUXdYbkhUek1na1Z3blBEWjJlaTVWNC1TRFFQcnRYUW9EUE1peWFGeWl6VEp4SC1xbUp1MUt0TEJXOEJid0lfZW1JYjhleDhtcGFEQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-10T08:04:04+00:00", "published_display": "10 Jul 2026 08:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Agilent (A) Signal a Deeper Shift With New AI Biopharma Tools and Columns?", "summary": "Agilent Technologies has expanded its Altura HPLC column portfolio and introduced the AI-powered xCELLigence RTCA eSight AI module, aiming to enhance data quality, efficiency, and reproducibility in biopharmaceutical research. This move aligns with Agilent's strategy to focus on ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-signal-a-deeper-shift-with-new-ai-biopharma-t", "source_name": "Simply Wall Street", "published_at": "2026-07-10T06:43:59", "published_display": "10 Jul 2026 06:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Strengthens Biopharma Growth Prospects With AI Expansion", "summary": "Agilent Technologies is enhancing its biopharma growth prospects by expanding its AI-enabled laboratory software and automation capabilities, despite recent stock dips. The company launched xCELLigence RTCA eSight AI to simplify live-cell imaging analysis and is integrating AI ac", "url": "https://www.tradingview.com/news/zacks:f7a7597dd094b:0-agilent-strengthens-biopharma-growth-prospects-with-ai-expansion/", "source_name": "TradingView", "published_at": "2026-07-09T18:07:10", "published_display": "09 Jul 2026 18:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies Inc. stock outperforms competitors on strong trading day", "summary": "Shares of Agilent Technologies Inc. (A) rose 3.50% on a strong trading day, outperforming the S&P 500 Index (SPX) and the Dow Jones Industrial Average (DJIA). The stock closed at $133.59, 16.65% below its 52-week high. This performance occurred as the broader market also saw gain", "url": "https://www.marketwatch.com/data-news/agilent-technologies-inc-stock-outperforms-competitors-on-strong-trading-day-a0e33dbe-50606b327369", "source_name": "MarketWatch", "published_at": "2026-07-09T16:53:00", "published_display": "09 Jul 2026 16:53", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat (NASDAQ:ILMN)", "summary": "Illumina (ILMN) holds over 90% market share in genomics sequencing with a robust razor-and-blades model, powering a $30B+ market. Following the GRAIL divestment, management is focusing on core sequencing, cost control, and capital return, leading to revenue recovery and margin ex", "url": "https://seekingalpha.com/article/4920921-while-you-chased-ai-this-healthcare-stock-built-a-30b-moat", "source_name": "Seeking Alpha", "published_at": "2026-07-09T15:10:27", "published_display": "09 Jul 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies explores long-term growth drivers as a life sciences leader", "summary": "Agilent Technologies Inc. is a leading provider of analytical instruments and diagnostic solutions for various industries, including pharmaceuticals and chemicals. The company focuses on high-performance systems like chromatography and mass spectrometry, benefiting from recurring", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-explores-long-term-growth-drivers-as-a-life-sciences/69730476", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T09:43:59", "published_display": "09 Jul 2026 09:43", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies resumes Agilent stock coverage with Hold rating By Investing.com", "summary": "Jefferies has resumed coverage on Agilent Technologies Inc. (NYSE:A) with a Hold rating and a $135 price target, following the company's acquisition of Biocare. The firm expects modest revenue growth and adjusted operating margin accretion from the deal, with slight dilution to e", "url": "https://za.investing.com/news/stock-market-news/jefferies-resumes-agilent-stock-coverage-with-hold-rating-93CH-4361430", "source_name": "Investing.com South Africa", "published_at": "2026-07-08T22:36:58", "published_display": "08 Jul 2026 22:36", "sentiment": "positive", "sentiment_pct": 60, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies resumes Agilent stock coverage with Hold rating", "summary": "Jefferies has resumed coverage on Agilent Technologies Inc. (NYSE:A) with a Hold rating and a price target of $135, following the company's acquisition of Biocare. The firm anticipates modest revenue growth and improved operating margins from the acquisition, though slight diluti", "url": "https://www.investing.com/news/analyst-ratings/jefferies-resumes-agilent-stock-coverage-with-hold-rating-93CH-4782704", "source_name": "Investing.com", "published_at": "2026-07-08T21:51:59", "published_display": "08 Jul 2026 21:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors", "summary": "Agilent Technologies Inc. (A) stock fell 1.58% to $129.07 on Wednesday, underperforming the broader market, as the S&P 500 Index (SPX) dropped 0.28% and the Dow Jones Industrial Average (DJIA) fell 1.09%. The company's stock closed 19.47% below its 52-week high of $160.27.", "url": "https://www.marketwatch.com/data-news/agilent-technologies-inc-stock-underperforms-wednesday-when-compared-to-competitors-d7e40d28-591b52143847?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-08T16:52:00", "published_display": "08 Jul 2026 16:52", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?", "summary": "Evercore ISI analyst Vijay Kumar recently raised the price target for Agilent Technologies, Inc. (A) to $148, maintaining an Outperform rating, following a review of the MedTech, Life Sciences Tools, and Diagnostics sectors. The positive outlook is supported by stable procedure v", "url": "https://www.insidermonkey.com/blog/is-agilent-technologies-inc-a-stock-positioned-for-growth-as-life-sciences-sector-trends-stabilize-1797685/", "source_name": "Insider Monkey", "published_at": "2026-07-08T15:06:58", "published_display": "08 Jul 2026 15:06", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Slumps on Expansion Plans", "summary": "Agilent Technologies Inc. (NYSE: A) shares declined after the company announced an expansion of its Altura HPLC column portfolio, introducing Altura size exclusion chromatography (SEC) and Altura PLRP-S columns. These new columns are designed to support critical analytical workfl", "url": "https://www.baystreet.ca/stockstowatch/23617/Agilent-Slumps-on-Expansion-Plans", "source_name": "Baystreet.ca", "published_at": "2026-07-08T14:06:58", "published_display": "08 Jul 2026 14:06", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/agilent-expands-altura-portfolio-inert-120000327.html", "source_name": "Business Wire", "published_at": "2026-07-08T12:00:00+00:00", "published_display": "08 Jul 2026 12:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Bravo NGS Auto Prep System from Agilent Technologies Inc. - Automating genomic workflows for", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQU2tETjdOa3FxTjdDQVhWTGRMak5aLXNBeUdNdXVWaTl6VXpoOF9XZjZxajhyYWNzaDl0dGUwSmlYOGhKTHFhTkJHQ2hkNVJ0VXdOemZSRkFjSWctNE5TTC1Tc3VYZEwydVhXUDdldTJud3BhR3BCX0UybzlnVkF0VVF1d0k5end0LTY5N0djajRmN3NMOUhBS05scl9qbk1OeTVDSUE5V3dBR2NVRkhnUk12Mk9uWVk0N2Qwb2ZRQk0?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-30T15:56:07+00:00", "published_display": "30 Jun 2026 15:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOQ3dIcEY1SVlJRzRVdm1YbDVMRTdody00UzB0OUhFQVhvenJBNERmNDlBbmZMMEZETzJaeVZfekJvYm9lYkVTdl8tbllZbUcxN1poZmFqX0I2ZXFzUE8zdV9TWlFUSXJUbkhDMFoxOW43amQyX1NzanNIZHI3YVFaZ1VkX1NqLTE0X3REem5paUVEc2dUMzJWSUtLVFhybm8?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Agilent\u2019s Upgraded Outlook and Cancer Diagnostics Push Could Impact Agilent Technologies (A) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-23T17:37:08+00:00", "published_display": "23 Jun 2026 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies (A) Stock Could Be 21.1% Undervalued After Earnings Beat And Higher Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNT1RaR2w2WkZvV180Wl90bzBaVGZXQi1fT0ZlbjhXbzMxeGhjLWVzWEI0V0d1a0NrUV9keHpGclV2NWYzNnB6a1F6YTZUOGliT1RVZDJiYnhhcG5yTkl1RlgtZ3dnZUhtV1VsTjlMNTlxSWQySVIyMUFyVmRubXRHd2Vmek1zVDZtRExYNHRkelhCM0ZmVlVWMDBjYi03OVZNc0gyeGNpTDRMcjZiU3VabVZEMldObDlOS3VzVkt1WHlPcDE1c1RkdTZhc0NwLUF3ekE4RmFwNUVVM21EVUd2YmdR0gHnAUFVX3lxTE5YOTBENzVDdi1OelFMX1hfMFNKZFhySW1wZk9IWkpfWk1iY1U4SjMyTW1PcVZLQVNBcTdUNWJta0h2aEQ1NDN1b0ZzbzB5bnRaNGMwdzFQMmhwR1hYYkxFVUowV1Z0ZTBucE5SLW5wR2NsUW54UURZU1h3OWVFUWk1NTBDOGpWVjd5bmxNajBhcW9LaGUwZm9CdUUxRFJ6MGVGNmtCdnNXT0E0OTBLR0VHNjc3X3MxY0F6V19yTkhFQkREUDdIbVliNVo2eTZHaUhHcEwxd0V0STNram5hMmdWMWZaR05tSQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies Inc. stock (US00846U1016): shares advance after stronger Q2 2026 results and hi", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVkFwNXRTZWNUbnRtV09YRGRSWW5DYjF2OVE1Mk5YZkdwVEpaRmdZSXM2aFlTNWpid0g5aVNYbTg1UHpxaEhudGhoV3ZrVkhQYjF6UEk0UnNpaXJDOXJ4em5ySjFkdkx5VnBXdGRYa250X0pJanRCcEtTN2t3NHJPbzh4bnFDb1lad0N3NDZEU2JJVlJSdV8ybkxGMkFkNllWMFBKNGx1d3E1d1BSZl9LaGRudmFsZHNrcV9XWF9iX04?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "StockWatch: Agilent Shares Jump on Better than Expected Quarterly Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPaXdkbXdJUktZd1FBOEZsY21zUlRBYXNpNmxDWXVhdERad0hqUDdOZlIwOVh1VnRlVWRuOURwUEVqUWV6NHVwWk5IRjBuRTJnejJQNVJFVVNCOF9zNXRfOW0teWJrTHNXSEpzSW93U1B6cnlVTWkzMGhFRzBiTm5qYTlybmpEbUhybTlUQ0drcDhKTjhqLUVuekFzWDZoVktUTUFUekhhWDRnTXJHX2d3a01oXzVYemoyWVc0QklB?oc=5", "source_name": "Genetic Engineering and Biotechnology News", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Agilent Technologies (A) After Its Recent Share Price Surge", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Agilent tool turns paper lab procedures into guided digital workflows", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQNlFZZ2Z0cFZLMTFudEtpZDZTN05pVS1LNDlFcVBDM0ZjTE4xSVpRdWVoWXM2OFVsVWFIcExNNGxuQWZIenh2dENLNzVpV2VYb1lMeUxFVWhIVVluLUxFekNsNFp0Rjc4OURnbU4yOFNQN190NlR6c25LUlpvb2plQmRWWHU4a1Rkb1BYT0VuamJnYkw3ZzBEWjE3QVd6RThMOThXekQzRUpRRDFpT0EwMTVBa2ZVR2d0OEF0UA?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A) Set to Report Earnings with Consensus at $1.41", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdDRyelY3WFFsaXZPbkJvRGw0TGlIWkY1M1lDeG8yV2gyU3ZOSjJtMlFoajZ4eFZqaWNBTFkxbnR0eG0zQzNvZ3NkU1Q0RkRtN3oxUWFtcnlKODU3MXlQZFNzVDVNZ3ZCUndxZ3lOTGRWV1JSM0x1QXNGcWdDMWlESExzY2dCeVZmNFp5UXR5c1hIXzRIV3FndlRqRktvVkc4SUFNa2hQMFQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Healthcare Providers & Services Stocks\u2019 Q1 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOWE1mb0V1RkxaUjhTeXBkZktWRVotYjBPbmg0QXMtbmJRVlpncWQxazh5LUVnTWNXYVNyT3RReWZyd0cyRmVFSHJiUnpscV91MDlpcWIzWFU5OE9DS09Od18xWGtfd3V6R0FYRWlRV1Z6Q2Vnc2tVRS03VkV4OGFxRzFrTlVGTFBtUnNMN3FuTjZHM0xBdHE0aWRpOVN1Z3hYR3RxM2JySnJrQ0Q1?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock (US00846U1016): Dividend hike follows mixed quarterly update", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPcjZjV0N5UmlMQm5BZUdmc1F2ZzJIWXpGRmZmTlphTVlJakRxWkhrWU1wRGx1S19sNlBySkZyS19pbXlWaHJnb2xDUko0bFNhRkZEdDhoZVctdlpPVlp4SVNvdFdrTVdiSENUdnpIdnpTTEVMd2hOa05rN0VzX2xxMTFCNG1VcnM2Zng1OUxDeEI3TFMtdjlDQ202eU9PdUxBTnRmRWlOY1FURVEwVGlRd2VGVmU2Ullmd21XekpMMzBLWG9s?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock (US00846U1016): Earnings update puts demand trends back in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQUhJczl2TVR6dlBYcWg3MzNjcExySm40ajB0NDZpaVVYT08zZU1RLURYQzlTc3c1Z2RCeHE0Y3RVWUhvZHpJcWpaNmMzNTQ1bnc3NWRZRzd1cFdxMU1UVEVrb09ZTjJFQnJVU1JYQjU1WEYwLWxFci1LM1YzeHdqWGNiVXJGS1FYaWhudmhqWm9MY21oMzlpRHlpWEVMQlhpRnl3MjZMemZFNVF6Wng0c2RYd3VqV1dEbWs2MFFabDhoSEZV?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies stock: Earnings update in focus after latest results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQbkZqSFZPSHdtQTFXV3Znakdsd0s4NE5BOW5wRDUzQ0toZmVJOHNGbkNpaDVMX0F5T2FMem41SDAwcFBNSFdCM1VoX244UE1nLVYxb001VGphY1h1OEJydF9hWnJMR2MzVWpHQWczWGFxVjRhVll2SWdGeTdNQjc4b2Fha2tRQXFwZzBfQ0JhTk44UVRTaUNnMnBwRDRXaVowaFR0WkJMbVB3UmtXbXRScjZ1NlpqUFBCc19XdE1uSVZvNG5jd29qVFFxUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent launches unified CDMO business combining US, Canada units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNZ20teFhQeXIwa2tHN29ha3lRS2hlMVkzTkE0QTlkRlczRlZRRUVBS3YtMGpRcmlXekFtYndianVJQVZBeE1yVk9rVFdnc0FPTXF4LVdyaXN6WXlmYnhSam1lNUlVN0piY3JHRjRNOHNWQ0NNWHVVWU03QmRUdWlSWkJlUEVtdlgtUUUxQ0J0N2NJZzdOaFNkcFJObWVMV3BHWnJ2alFIZHNRS1l1bUl2NWVOZDhfT0VTQ1EwTEp3?oc=5", "source_name": "Investing.com", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Agilent Stock Is Slipping Premarket Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPOUFTbjl6czVuX2hCOEk5RmRFMFVKOUFIa3d3Qlo5LXpwaFMtRG1jcXJuRDFlMlBJbW8yREFzQjJpZnBhUk9HSG5URE9kYlJrLWFGT3ZxTlBYV05hdllqVkFZQzBmdktqeWxDOXNONF9Xb01KbXB0NXVXcDljV2hSTnp4M3RsSUJ1VndsZmRoY3RtSFQ3aEQ0RGtZUTN2RlFnUkRuVHZ5aFhZUkppZlAyMEw0aG9PNFlQZ3FtakNOQTNObWNVd1JzYkxHN0pWTDNySnJ2NW9YQUJRMVhzZTJPSlBrbUk2dk5jN3pR?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent Technologies, Inc. (NYSE:A) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-27T08:00:00+00:00", "published_display": "27 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 107, "total_relevant": 44, "sentiment_summary": {"positive": 20, "negative": 2, "neutral": 22, "score": 59, "total": 44, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 74, "events": [{"event": "general", "label": "Market update", "weight": 10.05, "count": 17}, {"event": "earnings", "label": "Earnings", "weight": 7.5, "count": 13}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.75, "count": 5}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 20, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 134.29, "latest_week": "2026-07-10", "one_week_move": 2.8, "four_week_move": 3.6, "twelve_week_move": 10.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.889335, "market_dynamics_buy_signal": false, "relative_strength": -5.97964, "fair_value_gap": 5.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.7713, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.8% over one week, +3.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad-hoc-news.de", "count": 7}, {"label": "TradingView", "count": 5}, {"label": "simplywall.st", "count": 5}, {"label": "Investing.com", "count": 3}, {"label": "Market source", "count": 3}, {"label": "Investing.com South Africa", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "MarketWatch", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 44}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 17}, {"label": "Earnings", "count": 13}, {"label": "Regulatory and legal", "count": 5}, {"label": "Analyst action", "count": 3}, {"label": "Macro sensitivity", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "44", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.8% over one week, +3.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Life Science Tools Market Top Players- Agilent Technologies,"}], "updated_at": "2026-07-16T00:50:48.338572+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}